Gene therapy for RPE65-mediated inherited retinal dystrophy completes phase 3

被引：7
|
作者：
Lee, Helena [1 ]
Lotery, Andrew [1 ]
机构：
[1] Univ Southampton, Fac Med, Clin & Expt Sci, Southampton SO16 6YD, Hants, England
来源：
LANCET | 2017年 / 390卷 / 10097期
基金：
英国医学研究理事会;
关键词：
LEBERS CONGENITAL AMAUROSIS; ADENOASSOCIATED VIRUS; RPE65; MUTATIONS; SAFETY; TRIAL;
D O I：
10.1016/S0140-6736(17)31622-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：823 / 824
页数：2
相关论文
共 50 条
  • [41] Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial (vol 390, pg 849, 2017)
    Russell, S.
    Bennet, J.
    Wellman, J. A.
    Simonelli, Francesca
    LANCET, 2017, 390 (10097): : 848 - 848
  • [42] Functional outcomes and adverse effects of voretigene neparvovec for biallelic RPE65-mediated inherited retinal dystrophies in a cohort of patients from a single centre
    Kiraly, Peter
    Cottriall, Charles
    Taylor, Laura J.
    Jolly, Jasleen K.
    Cehajic-Kapetanovic, Jasmina
    Yusuf, Imran H.
    dela Camara, Cristina Martinez-Fernandez
    Shanks, Morag
    Downes, Susan M.
    MacLaren, Robert E.
    Fischer, Dominik M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [43] Results at 5 Years After Gene Therapy for RPE65-Deficient Retinal Dystrophy
    Pennesi, Mark E.
    Weleber, Richard G.
    Yang, Paul
    Whitebirch, Chris
    Thean, Beverly
    Flotte, Terence R.
    Humphries, Margaret
    Chegarnov, Elvira
    Beasley, Kathleen N.
    Stout, J. Timothy
    Chulay, Jeffrey D.
    HUMAN GENE THERAPY, 2018, 29 (12) : 1428 - 1437
  • [44] Outcomes and Adverse Effects of Voretigene Neparvovec Treatment for Biallelic RPE65-Mediated Inherited Retinal Dystrophies in a Cohort of Patients from a Single Center
    Kiraly, Peter
    Cottriall, Charles L.
    Taylor, Laura J.
    Jolly, Jasleen K.
    Cehajic-Kapetanovic, Jasmina
    Yusuf, Imran H.
    de la Camara, Cristina Martinez-Fernandez
    Shanks, Morag
    Downes, Susan M.
    MacLaren, Robert E.
    Fischer, M. Dominik
    BIOMOLECULES, 2023, 13 (10)
  • [45] NICE recommends gene therapy for inherited retinal dystrophy
    Mahase, Elisabeth
    BMJ-BRITISH MEDICAL JOURNAL, 2019, 366 : l5394
  • [46] Voretigene Neparvovec: A Review in RPE65 Mutation-Associated Inherited Retinal Dystrophy
    Kang, Connie
    Scott, Lesley J.
    MOLECULAR DIAGNOSIS & THERAPY, 2020, 24 (04) : 487 - 495
  • [47] Voretigene Neparvovec: A Review in RPE65 Mutation-Associated Inherited Retinal Dystrophy
    Connie Kang
    Lesley J. Scott
    Molecular Diagnosis & Therapy, 2020, 24 : 487 - 495
  • [48] Retinal Structure in RPE65-Associated Retinal Dystrophy
    Kumaran, Neruban
    Georgiou, Michalis
    Bainbridge, James W. B.
    Bertelsen, Mette
    Larsen, Michael
    Blanco-Kelly, Fiona
    Ayuso, Carmen
    Hoai Viet Tran
    Munier, Francis L.
    Kalitzeos, Angelos
    Michaelides, Michel
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (04)
  • [49] Frequency of RPE65 Gene Mutation in Patients with Hereditary Retinal Dystrophy
    Kahraman, Neslihan Sinim
    Oner, Ayse
    Ozkul, Yusuf
    Dundar, Munis
    TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY, 2022, 52 (04): : 270 - 275
  • [50] Gene therapy for RPE65-related retinal disease
    Utz, Virginia Miraldi
    Coussa, Razek Georges
    Antaki, Fares
    Traboulsi, Elias, I
    OPHTHALMIC GENETICS, 2018, 39 (06) : 671 - 677
12345